To amend the Public Health Service Act to reform the 340B drug pricing program, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill defines amendments to Section 340B(b) of the Public Health Service Act, provides 340B Drug Pricing Program Improvements, and provides hospital child site requirements. It relies on reporting requirements, compliance mandates, appropriations, and definition changes. The main policy areas are Healthcare and Finance.
Who Benefits and How
Covered Entities (Hospitals, Clinics, etc.) could gain revenue opportunities.
Who Bears the Burden and How
Group health plans, health insurance issuers, pharmacy benefit managers would take on compliance duties, Private nonprofit hospitals with contracts to provide health care services to low-income uninsured individuals would take on compliance duties, and Covered entities under Section 340B(d)(2)(B) would take on compliance duties.
Key Provisions
- Defines amendments to Section 340B(b) of the Public Health Service Act.
- Provides 340B Drug Pricing Program Improvements.
- Provides hospital child site requirements.
- Provides 340B Drug Pricing Program Expansion.
- Provides section 340B drug pricing affordability requirements.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill defines amendments to Section 340B(b) of the Public Health Service Act, provides 340B Drug Pricing Program Improvements, and provides hospital child site requirements.
Key Policy Areas
Healthcare, Finance
Primary Purpose
The bill defines amendments to Section 340B(b) of the Public Health Service Act, provides 340B Drug Pricing Program Improvements, and provides hospital child site requirements.
Policy Domains
Whole bill
Identified Gains
- Covered Entities (Hospitals, Clinics, etc.)
Identified Costs
- Group health plans, health insurance issuers, pharmacy benefit managers
- Private nonprofit hospitals with contracts to provide health care services to low-income uninsured individuals
- Covered entities under Section 340B(d)(2)(B)
- Covered entities described in subparagraphs (L) through (O)
- Covered entities described in subparagraph (L) of paragraph (4)
Sponsors
Legislative Progress
IntroducedMr. Carter of Georgia (for himself and Mrs. Harshbarger) introduced …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Covered Entities (Hospitals, Clinics, etc.), Covered entities and contract pharmacies, Covered entities described in subparagraphs (L) through (O)
Positive-direction: Covered Entities (Hospitals, Clinics, etc.), Covered entities described in subparagraphs (L) through (O), Nonhospital covered entities and subgrantees, Private nonprofit hospitals participating in Section 340B program
Negative-direction: Covered entities and contract pharmacies, Covered entities described in subsection (a)(4), Covered entities under Section 340B(a)(4)(A)-(K), Covered entities under Section 340B(d)(2)(B), Hospitals seeking 340B drug pricing program benefits
Contract Pharmacies, Covered entities described in subparagraph (L) of paragraph (4), Covered entities under the 340B program
Positive-direction: Covered entities under the 340B program
Negative-direction: Contract Pharmacies, Covered entities described in subparagraph (L) of paragraph (4), Off-campus outpatient facilities associated with covered entities, Private nonprofit hospitals with contracts to provide health care services to low-income uninsured individuals
Group health plans, health insurance issuers, pharmacy benefit managers
Third-party administrators and contract pharmacies serving covered entities under Section 340B
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
Key Definitions
Terms defined in this bill
any individual pharmacy (as determined by a national provider identifier unique to the pharmacy address) that is— (aa) (AA)licensed as a pharmacy by the relevant State (or States)
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology